体外受精中促性腺激素释放激素激动剂触发联合辅助低剂量人绒毛膜促性腺激素后黄体功能的独立血清标志物
本研究为前瞻性随机临床试验血清的二次分析,纳入30例40岁以下、有卵巢过度刺激综合征(OHSS)风险且血清E2<4,000 pg/mL的女性,比较GnRHa触发时给1,000 IU hCG与取卵时给1,500 IU hCG两种辅助方案。结果显示血清17OH-P于触发后5天早黄体期达峰、9天黄体中期降至低谷,肾素原于触发后2天达峰、9天降至低谷且与hCG时点无关;取卵时给hCG者黄体功能似更高,两种时点均足以挽救黄体并获妊娠,但取卵时hCG后黄体活性增加带来的OHSS风险应考虑。
要点
- 17OH-P于GnRHa触发后5天达峰、9天降至低谷。
- 肾素原于触发后2天达峰、9天降至低谷,与辅助hCG时点无关。
- 取卵时给hCG者黄体功能似高于触发时给药,两种时点均足以挽救黄体。
核心结论
- 以血清肾素原和17OH-P为替代指标判断,GnRHa触发后黄体功能仍持续。
- 两种辅助hCG时点均足以挽救黄体并获得成功妊娠,取卵时给hCG后黄体活性增加带来的OHSS风险应考虑。
研究设计与样本
- 前瞻性随机临床试验血清的二次分析,共30例受试者纳入本二次分析。
- 受试者为40岁以下、有OHSS风险且血清E2<4,000 pg/mL的女性,均采用GnRH拮抗剂方案行卵巢刺激。
- 受试者随机分为GnRHa触发时给1,000 IU hCG、取卵时给安慰剂,或触发时给安慰剂、取卵时给1,500 IU hCG。
- 主要结局指标为黄体期及早期妊娠的血清肾素原与17α-羟孕酮(17OH-P)曲线。
主要发现
- 血清17OH-P在早黄体期即GnRHa触发后5天达峰,于黄体中期即触发后9天降至低谷。
- 血清肾素原在黄体期即GnRHa触发后2天达峰,与辅助hCG给药时点无关,并于触发后9天降至低谷。
- 与触发时给辅助hCG相比,取卵时给辅助hCG时黄体功能似更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize corpora lutea (CL) function after gonadotropin-releasing hormone agonist (GnRHa) trigger with the use of adjuvant human chorionic gonadotropin (hCG). DESIGN: Secondary analysis of serum from prospective randomized clinical trial. SETTING: University-based fertility center. PATIENT(S): Women under 40 years of age at risk of ovarian hyperstimulation syndrome (OHSS) with serum E2 level <4,000 pg/mL. INTERVENTIONS(S): All subjects underwent ovarian stimulation with the use of a GnRH antagonist protocol. Within a larger study, subjects were randomized to receive 1,000 IU hCG at the time of GnRHa trigger and placebo at the time of vaginal oocyte retrieval (VOR) or placebo at the time of GnRHa trigger and 1,500 IU hCG at the time of VOR. MAIN OUTCOME MEASURE(S): Luteal phase and early pregnancy curves of serum prorenin and 17α-hydroxyprogesterone (17OH-P). RESULT(S): Thirty subjects enrolled in this secondary analysis. Serum 17OH-P peaked in the early luteal phase, 5 days after GnRHa trigger, with a nadir in the mid-luteal phase 9 days after trigger. Serum prorenin peaked in the luteal phase 2 days after GnRHa trigger, independently from adjuvant hCG timing, and reached a nadir at 9 days after trigger. CL function appears higher when adjuvant hCG is given at VOR compared with adjuvant hCG given at the time of trigger. CONCLUSION(S): CL function, as interpreted by proxy measures of serum prorenin and 17OH-P with pregnancy, continues despite GnRHa trigger. Both options for adjuvant hCG timing are sufficient for CL rescue and successful pregnancy, so the potential for OHSS risk with increased CL activity after hCG at VOR should be considered. CLINICAL TRIAL REGISTRATION NUMBER: NCT01815138.
引用
- Kaye L, Griffin D, Thorne J, et al. Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in vitro fertilization. Fertil Steril. 2019. PMID: 31227286. doi:10.1016/j.fertnstert.2019.04.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。